Aeovian Pharmaceuticals announced it raised $50.4 Million in an initial filing from an offering of $50.4 Million
Aeovian Pharmaceuticals announced it raised $50.4 Million in an initial filing from an offering of $50.4 Million
05/13/24, 4:55 PM
Location
berkeleyMoney raised
$50.4 million
Industry
biopharma
biotechnology
Company Info
Location
berkeley, california, united states
Additional Info
Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality control, thereby addressing the dysregulated growth and hyperactive signaling found in certain rare genetic and age-related diseases.